Parallel Advisors’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Parallel Advisors's VCYT Position: Q2 2026 in Review
Parallel Advisors increased its Veracyte (VCYT) stake by 1.6% in Q2 2026, buying an estimated $84 and bringing the position to 125 shares worth $7.34K. The position accounts for ﹤0.01% of the portfolio, ranked #3057.
Parallel Advisors first reported a position in VCYT in Q2 2019 and has held it in 21 quarters since. The position peaked at $339K in Q4 2024. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Parallel Advisors held 125 shares of Veracyte worth $7.34K as of Q2 2026.
- Parallel Advisors bought 2 Veracyte shares in Q2 2026, an estimated $84.
- Veracyte made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3057 holding.
- Parallel Advisors first reported a position in Veracyte in Q2 2019 and has held it in 21 quarters since.
- Parallel Advisors's Veracyte position peaked at $339K in Q4 2024.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.